Back to catalogue
№ 104 24 filings · 2022-06-08 → 2026-09-11

C&C GROUP PLC

CCR
Food, Beverage and Tobacco Share price 102p Market cap £377m Overall fit 210 /1000

Consumer-staples drinks distributor with essentially no AI-receiver exposure, modest and asymmetric operating leverage (Branded has some, MCB has almost none), fair valuation with no rerating catalyst, and moderate balance-sheet quality. Fails the strategy's three primary tests on AI exposure and operating leverage.

Fair value range 90p–120p Mid case · £387m
Absolute upside +2.8% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • EV/EBITDA and P/E approaches converge on similar range
  • Mature business with stable disclosure post-FY24 remediation
  • Multiple recent guidance points consistent with each other
Limits the call
  • Recurring large exceptional charges muddy earnings quality
  • September 2026 Capital Markets Day could reset the strategic outlook
Methodology

Blended EV/EBITDA (6.5-8x) and P/E (10-13x) on adjusted metrics

In one line · bull case

Stabilising UK/Ireland drinks business with strong regional brands (Tennent's, Bulmers) trading at fair value, offering capital return and modest self-help margin recovery but no structural growth or thematic catalyst.

In one line · biggest risk

Continued MCB Distribution margin compression from adverse category mix and weak hospitality demand caps profit recovery and could push the shares lower if FY27 disappoints.

Drivers
AI beneficiary 5 /100
Traditional drinks manufacturer/distributor with no AI supply-chain exposure or AI-augmented product economics.
Operating leverage 35 /100
Branded segment has modest fixed-cost gearing at Wellpark/Clonmel; MCB Distribution is thin-margin variable-cost — group blended leverage is limited.
Earnings vs expectations 40 /100
Mostly in-line versus revised guidance but with two material downward resets (FY24 restatement, FY26 January warning).
Growth momentum 25 /100
Revenue -5.7% in FY26, HY27 -3%; FY27 profit guided flat vs FY26.
Moat 45 /100
Tennent's and Bulmers are strong regional brands; MCB has scale in UK/Ireland hospitality distribution — narrow but real moats.
Earnings quality 40 /100
FY24 restatement, €40m+ annual exceptional charges, and cider brand impairments reduce confidence in reported earnings.
Management quality 40 /100
Multiple CEO/CFO transitions in 24 months, historical control failures, but new team delivering credible simplification.
Cyclicality 45 /100
Consumer staples cushion offset by hospitality-channel and discretionary-drinks demand sensitivity.
Leverage 45 /100
Net debt 1.6x EBITDA excl. leases, 2.5x incl. leases; RCF extends to 2030 with comfortable covenant headroom.
Value-trap signals · 5
  • Structurally declining Distribution revenue
  • Repeated large exceptional charges across multiple years
  • Brand impairments on legacy cider portfolio
  • Frequent senior management churn
  • Two AGM resolutions requiring shareholder-concerns consultation

C&C Group PLC (CCR) — Investment Research Note

Executive summary

C&C Group is a UK/Ireland vertically-integrated drinks business combining a Branded portfolio (Tennent's #1 Scottish beer, Bulmers #1 Irish cider, Magners, Menabrea, plus recently acquired Innis & Gunn) with Matthew Clark Bibendum (MCB), the #1 drinks distributor to UK/Ireland hospitality. Across the period covered, operating profit recovered from a €60.0m ERP-disrupted FY24 to €77.1m in FY25, then slipped back to €70.5m in FY26 as consumer demand weakened and Distribution margin was squeezed by mix-shift away from wine/spirits 2025-05 FY25 results, 2026-05 FY26 results. The single most important valuation point today is that the business has stabilised operationally but structural growth is absent — the shares now trade at ~11–12x adjusted EPS and ~6.7x EV/EBITDA, roughly in line with intrinsic value with no clear rerating catalyst.

Fair value estimate

  • Fair value range: 90–120p per share (implied market cap £332m–£442m)
  • Methodology: blended EV/EBITDA (6.5–8.0x on run-rate adjusted EBITDA of ~€100m, subtracting pre-IFRS16 net debt of €121.4m plus lease debt €139m, translated at EUR/GBP ~0.86) and P/E (10–13x on adjusted diluted EPS of ~10c ≈ 8.6p). Both approaches converge on 90–120p.
  • Current market cap £372.9m sits inside this range; midpoint fair value ~105p vs price 101.2p.
  • Absolute upside/downside: approximately +4% to midpoint; view: fair.

Sector context

  • Confirmed sector: Consumer Staples / Food, Beverage & Tobacco — but with a large Distribution segment that behaves more like a hospitality-linked wholesaler than a classic staples brand owner.
  • Quality/growth/leverage profile is below typical staples peers: gross-margin structure is weighed down by the 80%+ revenue share coming from thin-margin (1.5% op margin) Distribution 2026-05 FY26 results segment table. Growth is anaemic vs global staples peers; leverage at 1.6x is moderate.
  • Listed peers: Britvic, AG Barr, Fevertree (Branded comparators); Marston's, Wetherspoons (hospitality demand read-across); larger reference points Heineken, Diageo, Molson Coors.

Investment thesis (3 bullets)

  • Fair valuation with self-help operational upside: FY26 exceptional charges of €40.7m (transformation, control remediation, brand impairment) have masked underlying earnings power; management targets progressive MCB margin recovery and further simplification, with the €100m medium-term EBIT target reiterated at FY25 results 2025-05 FY25 results, 2026-05 FY26 results.
  • Strong regional brand franchises: Tennent's and Bulmers each grew market share in their home markets in FY26 despite a weak backdrop, Branded operating margin expanded 110bps to 16.5%, and the Innis & Gunn (€5.1m, March 2026) and Asahi UK wholesale (nominal consideration, October 2026) bolt-ons are demonstrably synergistic given C&C's existing brewing and MCB distribution footprint 2026-05 FY26 results, 2026-03 Innis & Gunn, 2026-09 Asahi acquisition.
  • Committed capital return programme: €150m to be returned to shareholders across FY25–FY27 via dividends and buybacks; €105m cumulatively returned including the FY26 final dividend, with a €1bn share-premium capital reduction being implemented to unlock distributable reserves 2026-05 FY26 results.

Key risks (3 bullets)

  • Structurally weak MCB margins and volume-mix headwinds: Distribution operating margin fell from 2.3% to 1.5% in FY26 as consumers shifted from wine/spirits to beer; net revenue declined 8%, and FY27 guidance is for profits similar to FY26, i.e. no near-term recovery 2026-05 FY26 results, 2026-01 Jan 2026 trading update.
  • Track record of exceptional charges and control weaknesses: exceptional operating charges of €40.1m (FY26), €31.3m (FY25) and €144.4m (FY24); FY24 accounting restatement caused deferral of FY24 results and required extensive risk-management/control review costs; the €7.6m H1↔H2 profit reallocation was disclosed in the restated HY25 comparators 2024-10 HY25 interims Note 15, 2025-05 FY25 results, 2026-05 FY26 results.
  • Weak consumer/hospitality end-market and cost inflation: management flagged softer trading following the UK Autumn 2025 Budget and expects continued volatility; hospitality closures, DRS, EPR levies and NI rises all pressure customers, and the market cap has fallen ~40% over 12 months to 101p 2026-01 trading update, 2026-05 FY26 results, market data.

Operating leverage

Operating leverage is modest and split by segment. Branded is a moderately-leveraged asset-heavy business: production sites at Wellpark (Glasgow) and Clonmel (Tipperary) carry meaningful fixed depreciation (~€30m combined property/plant) and management explicitly notes retained spare capacity to respond to volume opportunities 2026-05 FY26 results. Branded operating margin expanded 110bps year-on-year on flat-to-modest revenue in FY26, consistent with genuine but limited fixed-cost gearing; 10–20% incremental revenue in Branded could plausibly add ~30–50% to segment profit. Distribution (MCB) is the opposite: highly variable cost (haulage, product cost, casual labour) with 1.5% margin — a 10% revenue lift would probably add only ~30% to segment profit before it is diluted by category-mix effects. Blending the two, a 10–20% revenue beat at Group level would likely lift EBIT ~25–40%, i.e. meaningful but not multiples-of-profit. The recent 4% workforce reduction and depot consolidation (25 sites) provide some FY27 tailwind but again, not step-change leverage 2026-05 FY26 results.

Value-trap signals

  • Structurally declining Distribution revenue with margin erosion; management is actively exiting lower-margin business (planned revenue decline) 2026-01 trading update.
  • FY24 restatement and material control-remediation costs across FY25/FY26.
  • Multiple CEO/CFO transitions in 24 months (McMahon out June 2024, Findlay interim, White in Jan 2025; Andrea CFO out March 2026, Phillips in April 2026).
  • AGM 2026 Resolution 11 (EGM 14-day notice) received only 78.25% support; 2025 Resolution 8 (additional pre-emption) had 79.50%, both requiring shareholder consultation per UK CG Code — some governance friction 2026-07 AGM result, 2025-07 AGM result.
  • Non-cash brand impairments of €15.6m (Gaymers/Orchard Pig cider) taken in FY26 signal genuine erosion of legacy cider brand value.

Earnings vs expectations

  • FY24: Deep miss vs prior guidance — ERP disruption, restatement of prior periods, €125m goodwill impairment 2025-05 FY25 results Note 3.
  • HY25 (Aug 2024): In line with revised expectations (op profit €40.3m before exceptionals) 2024-10 HY25 interims.
  • FY25: Met expectations — €77.1m op profit vs guided €76-78m in March 2025 pre-close 2025-03 trading update, 2025-05 FY25 results.
  • HY26 (Aug 2025): In line — €41.9m op profit 2025-10 HY26 interims.
  • FY26: Guidance cut in January 2026 (from prior implied ~€80m to €70–73m); delivered €70.5m — met the downgraded guidance but missed original 2026-01 trading update, 2026-05 FY26 results.
  • HY27 (Aug 2026): In line — €43–44m op profit guided 2026-09 acquisition and trading update.

Pattern: mostly in-line-to-modest-beat vs the most recently revised guidance, but with two material downward resets in the period (FY24 restatement/impairments; FY26 January warning). Not a "beat consistently" story.

Conviction

Conviction: 4 (high) — the filings are detailed and consistent, multiple valuation approaches (EV/EBITDA and P/E) converge on a similar range (90–120p), the business is mature with well-understood economics, and the current 101p price sits squarely in fair-value territory. What limits me from a 5 is (a) the FY24 restatement and non-trivial exceptional charges every year erode confidence in reported earnings quality, and (b) September 2026's Capital Markets Day and the FY27 Asahi UK integration could genuinely shift the profit trajectory in ways not yet in filings.

For this investor profile: this is a poor fit. Zero AI-receiver exposure, limited operating leverage, moderate downside protection but no thematic upside. Fair price for a fairly-boring, mid-single-digit-margin drinks business with structural growth challenges.

Filings consulted · 26

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-11Acquisition And Trading Update2026-09-11_9766652_acquisition-and-trading-update.md0.85
  2. 2026-08-05Notice OF Capital Markets Day2026-08-05_9704907_notice-of-capital-markets-day.md0.95
  3. 2026-07-10Result OF Agm2026-07-10_9663761_result-of-agm.md0.30
  4. 2026-06-12Annual Report And Notice OF Agm2026-06-12_9616086_annual-report-and-notice-of-agm.md0.95
  5. 2026-05-19Final Results2026-05-19_9574215_final-results.md1.00
  6. 2026-03-06Acquisition OF Innis Amp Gunn Brand2026-03-06_9462992_acquisition-of-innis-amp-gunn-brand.md0.64
  7. 2026-01-23Fy26 Trading Update2026-01-23_9378314_fy26-trading-update.md0.72
  8. 2025-10-28Interim Results2025-10-28_9197743_interim-results.md0.77
  9. 2025-09-18Fy2026 First Half Trading Update2025-09-18_9115206_fy2026-first-half-trading-update.md0.72
  10. 2025-07-14Result OF Agm2025-07-14_8976597_result-of-agm.md0.20
  11. 2025-06-16Annual Report And Notice OF Agm2025-06-16_8931638_annual-report-and-notice-of-agm.md0.62
  12. 2025-05-28Final Results2025-05-28_8899222_final-results.md0.65
  13. 2025-03-13Trading Update2025-03-13_8776685_trading-update.md0.55
  14. 2025-02-25Notice OF Pre Close Trading Update2025-02-25_8750464_notice-of-pre-close-trading-update.md0.55
  15. 2024-10-29Interim Results2024-10-29_8514423_interim-results.md0.58
  16. 2024-09-09Fy2025 First Half Trading Update2024-09-09_8405293_fy2025-first-half-trading-update.md0.38
  17. 2024-08-15Result OF Agm2024-08-15_8369623_result-of-agm.md0.14
  18. 2024-08-15Agm Trading Update And Directorate Change2024-08-15_8367556_agm-trading-update-and-directorate-change.md0.38
  19. 2024-07-31Response TO Shareholder Letter2024-07-31_8341385_response-to-shareholder-letter.md0.38
  20. 2024-07-17Notice OF Agm2024-07-17_8316877_notice-of-agm.md0.14
  21. 2024-06-24Response TO Shareholder Letter2024-06-24_8275055_response-to-shareholder-letter.md0.38
  22. 2024-05-10Timing OF Fy2024 Full Year Results2024-05-10_8187308_timing-of-fy2024-full-year-results.md0.45
  23. 2023-07-13Result OF Agm2023-07-13_7631157_result-of-agm.md0.07
  24. 2023-06-14Annual Report Amp Notice OF Agm2023-06-14_7574365_annual-report-amp-notice-of-agm.md0.24
  25. 2022-07-07Result OF Agm2022-07-07_6920664_result-of-agm.md0.07
  26. 2022-06-08Annual Report And Notice OF Agm2022-06-08_6868774_annual-report-and-notice-of-agm.md0.24

This research note was authored by a large language model after reading 24 regulatory filings published between 2022-06-08 and 2026-09-11. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.